Matthew R. Kane - Net Worth and Insider Trading
Matthew R. Kane Net Worth
The estimated net worth of Matthew R. Kane is at least $623,647 dollars as of 2024-09-20. Matthew R. Kane is the President and CEO of Precision BioSciences Inc and owns about 65,855 shares of Precision BioSciences Inc (DTIL) stock worth over $623,647. Details can be seen in Matthew R. Kane's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew R. Kane has not made any transactions after 2021-04-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew R. Kane
Matthew R. Kane Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew R. Kane owns 1 companies in total, including Precision BioSciences Inc (DTIL) .
Click here to see the complete history of Matthew R. Kane’s form 4 insider trades.
Insider Ownership Summary of Matthew R. Kane
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DTIL | Precision BioSciences Inc | 2021-04-12 | director & 10 percent owner & President and CEO |
Matthew R. Kane Latest Holdings Summary
Matthew R. Kane currently owns a total of 1 stock. Matthew R. Kane owns 65,855 shares of Precision BioSciences Inc (DTIL) as of April 12, 2021, with a value of $623,647.
Latest Holdings of Matthew R. Kane
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DTIL | Precision BioSciences Inc | 2021-04-12 | 65,855 | 9.47 | 623,647 |
Holding Weightings of Matthew R. Kane
Matthew R. Kane Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew R. Kane has made a total of 8 transactions in Precision BioSciences Inc (DTIL) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Precision BioSciences Inc is the sale of 325 shares on April 12, 2021, which brought Matthew R. Kane around $84,455.
Insider Trading History of Matthew R. Kane
- 1
Matthew R. Kane Trading Performance
Matthew R. Kane Ownership Network
Matthew R. Kane Owned Company Details
What does Precision BioSciences Inc do?
Who are the key executives at Precision BioSciences Inc?
Matthew R. Kane is the director & 10 percent owner & President and CEO of Precision BioSciences Inc. Other key executives at Precision BioSciences Inc include General Counsel Dario Scimeca , 10 percent owner J. Jefferson Smith , and Chief Medical Officer Alan List .
Precision BioSciences Inc (DTIL) Insider Trades Summary
Over the past 18 months, Matthew R. Kane made no insider transaction in Precision BioSciences Inc (DTIL). Other recent insider transactions involving Precision BioSciences Inc (DTIL) include a net sale of 51,036 shares made by Dario Scimeca , a net sale of 310,940 shares made by Michael Amoroso , and a net sale of 29,825 shares made by Alan List .
In summary, during the past 3 months, insiders sold 0 shares of Precision BioSciences Inc (DTIL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,536 shares of Precision BioSciences Inc (DTIL) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 13,536 shares.
Precision BioSciences Inc (DTIL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Precision BioSciences Inc Insider Transactions
Matthew R. Kane Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew R. Kane. You might contact Matthew R. Kane via mailing address: C/o Precision Biosciences, Inc., 302 East Pettigrew Street, Suite A-100, Durham Nc 27701.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
